Sopheon plc (“Sopheon”), the international provider of software and services that improve the return from innovation and new product development investments, is pleased to announce that at its general meeting held earlier today, the resolution to approve the proposed share subdivision was passed.
Under the share subdivision every existing ordinary share of £100 each will be subdivided into 500 new ordinary shares of 20p each ("New Ordinary Shares"). The rights attaching to the New Ordinary Shares will be identical in all other respects to those of the existing ordinary shares.
Application has been made for the 7,279,000 New Ordinary Shares to be admitted to trading on AIM and Alternext ("Admission") and dealings are expected to commence at 8.00 a.m. on 22 December 2014 with ISIN GB00BSZM1369. Due to differences in the settlement mechanisms between the Netherlands and the UK, the record date set out in the timetable for shares in the Netherlands is two days later than in the UK. Notwithstanding the foregoing, trading in the New Ordinary Shares will commence on both AIM and Alternext on 22 December 2014. The full timetable was published in Sopheon’s announcement dated 2 December 2014.
Following the share consolidation there will be 7,279,000 New Ordinary Shares in issue. The Company does not hold any shares in treasury. Therefore the total number of shares with voting rights in the Company following Admission will be 7,279,000. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.
For Further Information Contact:
|Barry Mence, Chairman||Sopheon plc||+ 44 (0) 1483 685 735|
|Arif Karimjee, CFO||Sopheon plc||+ 44 (0) 1483 685 735|
|Charlotte Stranner / Victoria Bates||finnCap||+ 44 (0) 20 7600 1658|
|Heather Armstrong||Newgate Threadneedle||+ 44 (0) 20 7653 9842|
|Claire Verhagen||Citigate First Financial||+ 31 (0) 205 754 010|
Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands.